CELL DEATH AND IMMUNE PRIVILEGE
- 1 January 2002
- journal article
- review article
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 21 (2-3) , 153-172
- https://doi.org/10.1080/08830180212058
Abstract
The host response to pathogens involves complex inflammatory responses and immune reactions. While these are central to host defense and vital to clearing infections, they are often accompanied by injury to surrounding tissue. Most organ systems can tolerate these responses without permanent consequences. However, there are sites that limit the spread of inflammation because it can threaten organ function. The most prominent examples of these are the eye, brain, and reproductive organs (testis, ovary), where even minor bouts of inflammation can have long-term consequences for the survival of the organism. In these organs immune responses either do not proceed, or proceed in a manner different from other areas; thus, they are called "immunologically privileged." Here a functioning immune response can be the culprit that leads to disease.Keywords
This publication has 45 references indexed in Scilit:
- TGF-β Released by Apoptotic T Cells Contributes to an Immunosuppressive MilieuImmunity, 2001
- Selective Upregulation of Fibroblast Fas Ligand Expression, and Prolongation of Fas/Fas Ligand-Mediated Skin Allograft Survival, by Retinoic Acid: the Skin as a Retinoide-Inducible Immune Privilege SiteJournal of Investigative Dermatology, 2000
- Fas ligand gene transfer combined with low dose cyclosporine A reduces acute lung allograft rejectionTransplant International, 2000
- Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand–deficient miceJournal of Clinical Investigation, 2000
- Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching systemGene Therapy, 1998
- Anterior chamber inoculation of splenocytes without Fas/Fas‐ligand interaction primes for a delayed‐type hypersensitivity response rather than inducing anterior chamber‐associated immune deviationEuropean Journal of Immunology, 1997
- Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in MiceScience, 1996
- CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological ToleranceImmunity, 1996
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- The regulation by light of retinal necrosis and the immune response following anterior chamber inoculation of herpes simplex virus type-1Archiv für die gesamte Virusforschung, 1993